Targeting Molecular Chaperones for the Treatment of Cystic Fibrosis: Is It a Viable Approach?

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|16|9|958-964

ISSN： 1389-4501

Source： Current Drug Targets, Vol.16, Iss.9, 2015-01, pp. : 958-964

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting ENaC as a Molecular Suspect in Cystic Fibrosis

By  

Current Drug Targets, Vol. 16, Iss. 9, 2015-01 ,pp. : 951-957

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting neutrophil elastase in cystic fibrosis

By Kelly Emer   Greene Catherine M   McElvaney Noel G  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 2, 2008-02 ,pp. : 145-157

Informa Healthcare

Access to resources Recommend Favorite

Targeting the Root Cause of Cystic Fibrosis

By  

Current Drug Targets, Vol. 16, Iss. 9, 2015-08 ,pp. : 933-944

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Emerging Molecular Targets for the Treatment of Cystic Fibrosis)

By  

Current Drug Targets, Vol. 16, Iss. 9, 2015-01 ,pp. : 922-922

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in the treatment of cystic fibrosis

By  

Inpharma, Vol. 1, Iss. 1376, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite